ABT vs FBYDW
Abbott Laboratories (ABT) versus Falcon's Beyond Global, Inc. Warrants (FBYDW) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Falcon's Beyond Global, Inc. Warrants (FBYDW) is a conglomerates company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
FBYDW does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. FBYDW currently screens at market cap $0.
Not investment advice. Open the ABT and FBYDW stock pages for the full models.
Not investment advice.